We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
351
Charles River Laboratories
CRL
$13.3B
$48.7M 0.04%
223,717
-7,786
-3% -$1.7M
SAP icon
352
SAP
SAP
$244B
$48.5M 0.04%
470,250
+48,699
+12% +$4.88M
MGV icon
353
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.6B
$48.5M 0.04%
471,657
+31,441
+7% +$3.16M
SPAB icon
354
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.92B
$48.3M 0.04%
1,923,825
-1,009,411
-34% -$25.3M
HEI.A icon
355
HEICO Corp Class A
HEI.A
$37.4B
$48.3M 0.04%
403,302
+1,184
+0.3% +$144K
SHEL icon
356
Shell
SHEL
$250B
$48.2M 0.04%
846,014
+45,296
+6% +$2.5M
VBK icon
357
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.7B
$48M 0.04%
239,124
+21,609
+10% +$4.42M
BALL icon
358
Ball Corp
BALL
$16.7B
$47.8M 0.04%
935,327
+97,353
+12% +$5.04M
YUMC icon
359
Yum China
YUMC
$16.2B
$47.6M 0.04%
871,334
+10,090
+1% +$513K
DHI icon
360
D.R. Horton
DHI
$41.7B
$47.4M 0.04%
531,896
+271,273
+104% +$21.7M
PPL
361
PPL Corp
PPL
$26.4B
$47.2M 0.04%
1,614,624
-16,926
-1% -$465K
FDS icon
362
Factset
FDS
$10.1B
$47.1M 0.04%
117,464
-1,526
-1% -$650K
ILMN icon
363
Illumina
ILMN
$29B
$47M 0.04%
238,856
+10,918
+5% +$2.26M
SRLN icon
364
State Street Blackstone Senior Loan ETF
SRLN
$5.35B
$47M 0.04%
1,148,561
-88,792
-7% -$3.66M
KKR icon
365
KKR & Co
KKR
$97.1B
$46.9M 0.04%
1,009,669
-84,660
-8% -$4.13M
ICLR icon
366
Icon
ICLR
$12.7B
$46.7M 0.04%
240,584
-3,994
-2% -$792K
APTV icon
367
Aptiv
APTV
$10.4B
$46.5M 0.04%
499,006
+209,855
+73% +$19.9M
SNY icon
368
Sanofi
SNY
$105B
$46.3M 0.04%
955,401
+156,392
+20% +$6.86M
PINC
369
DELISTED
Premier
PINC
$46.2M 0.04%
1,319,646
-134,903
-9% -$4.5M
CSX icon
370
CSX Corp
CSX
$92.7B
$46.1M 0.04%
1,487,589
+43,990
+3% +$1.32M
ACWI icon
371
iShares MSCI ACWI ETF
ACWI
$33.4B
$46M 0.04%
541,402
+280,243
+107% +$23.6M
IWN icon
372
iShares Russell 2000 Value ETF
IWN
$14.6B
$45.9M 0.04%
331,356
+5,986
+2% +$845K
FPE icon
373
First Trust Preferred Securities and Income ETF
FPE
$6.33B
$45.9M 0.04%
2,733,054
+173,698
+7% +$2.91M
YUM icon
374
Yum! Brands
YUM
$39.1B
$45.8M 0.04%
357,696
-1,160
-0.3% -$141K
URI icon
375
United Rentals
URI
$72B
$45.6M 0.04%
128,334
-6,856
-5% -$2.25M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.